On March 18, the Parliamentary Committee for Allergic Diseases held another meeting in the Polish Parliament. The event, led by Maja Nowak, Member of the Polish Parliament, focused on biological treatment for allergic and lifestyle diseases – particularly topics such as treatment availability and its clinical, economic, and systemic aspects.
On behalf of the PTA and the Asthma Treatment Coalition, the meeting was attended by: Prof. Marek Kulus – Chairman of the Coalition; Dr. hab. Aleksandra Kucharczyk – Chair of the PTA Biological Therapy Section.
Also participating were Prof. Karina Jahnz-Różyk – National Consultant in Allergology; Dr. hab. Piotr Dąbrowiecki – Chairman of the Polish Federation of Asthma, Allergy, and COPD Patients’ Associations; and representatives of the Ministry of Health, AOTMiT, other non-governmental organizations, and experts in related specialties. During the discussion, representatives of the PTA and the Coalition presented the allergists’ proposals for modifying and streamlining drug programs. We hope that the work of the Parliamentary Group will positively impact the wider availability of biological treatments and their appropriate funding, especially for allergic diseases.
Latest news
Project LungHealth4Life (LH4L)
The LungHealth4Life (LH4L) project is a project co-financed by the European Commission under the EU4Health program, launched in September 2024. The project is dedicated to
Position on the transition of medical aerosols in the light of EU environmental regulations
Specialists in the fields of allergology, pulmonology, pediatric pulmonology and family medicine have prepared a joint position on the transition of medical aerosols in light
The MASK-air application has been certified by the Ministry of Health
We are pleased to announce that thanks to the efforts of the Polish Society of Allergology, the MASK-air application has been certified by the Ministry
New GINA
The new GINA has already been published – a document necessary for every doctor dealing with asthma. We invite you to read this study at https://ginasthma.org/2024-report/





